{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:01:17Z","timestamp":1780941677561,"version":"3.54.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["19H01114, 18KK0253, and 20K09784"],"award-info":[{"award-number":["19H01114, 18KK0253, and 20K09784"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"crossref","award":["the Research Funding for Longevity Sciences (22-25)"],"award-info":[{"award-number":["the Research Funding for Longevity Sciences (22-25)"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    The accumulation of advanced glycation end products (AGEs) is a risk factor for renal dysfunction. However, no investigation has been conducted on the association between AGEs and renal function in health screening participants. Therefore, this study aimed to examine the association between AGEs and kidney function in health screening participants who underwent health screening examination. Overall, 1,651 health screening examinees without a history of renal dysfunction diagnosis were recruited and AGE accumulation was measured by skin autofluorescence (SAF). The association between estimated glomerular filtration rate (eGFR) and AGEs was subsequently investigated in all examinees. The mean age was 56.6\u2009\u00b1\u20099.5 years; 812 (49.1%) were males, and the mean eGFR was 73.3\u2009\u00b1\u200913.4 mL\/min. Multiple regression analysis identified that AGEs were significantly negatively associated with eGFR. This finding was also observed in examinees with normal eGFR (\u2267 90 mL\/min\/1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    , G1 stage according to the Japanese Society of Nephrology: N\u2009=\u2009207). In conclusion, skin AGEs were significantly negatively associated with eGFR. To clarify whether AGEs contribute to renal dysfunction progression, additional research is required.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0351398","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:32:42Z","timestamp":1780939962000},"page":"e0351398","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advanced glycation end product accumulation was associated with renal function impairment in males in large health examination population"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8399-8210","authenticated-orcid":true,"given":"Ryo","family":"Asaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7930-3618","authenticated-orcid":true,"given":"Akira","family":"Obana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"12","key":"pone.0351398.ref001","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejheart.2007.09.009","article-title":"Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications","volume":"9","author":"JWL Hartog","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"pone.0351398.ref002","article-title":"Reactive carbonyl compounds related uremic toxicity (\u201ccarbonyl stress\u201d)","volume":"78","author":"T Miyata","year":"2001","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"pone.0351398.ref003","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI119180","article-title":"Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging","volume":"99","author":"ED Schleicher","year":"1997","journal-title":"J Clin Invest"},{"issue":"6","key":"pone.0351398.ref004","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bjo.85.6.746","article-title":"Advanced glycation: an important pathological event in diabetic and age related ocular disease","volume":"85","author":"AW Stitt","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"pone.0351398.ref005","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/CIRCULATIONAHA.105.575993","article-title":"Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury","volume":"113","author":"LG Bucciarelli","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"pone.0351398.ref006","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00467-012-2280-z","article-title":"Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease","volume":"28","author":"I Makulska","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"pone.0351398.ref007","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/02713683.2014.918152","article-title":"Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes","volume":"40","author":"M Yasuda","year":"2015","journal-title":"Curr Eye Res"},{"key":"pone.0351398.ref008","first-page":"156","article-title":"Advanced glycation and retinal pathology during diabetes","author":"AW Stitt","year":"2005","journal-title":"Pharmacol Rep"},{"issue":"5","key":"pone.0351398.ref009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jdiacomp.2014.03.003","article-title":"Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients","volume":"28","author":"T Hirano","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"4","key":"pone.0351398.ref010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamaophthalmol.2013.7664","article-title":"Serum Carboxymethyllysine, an Advanced Glycation End Product, and Age-Related Macular Degeneration","volume":"132","author":"RD Semba","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"pone.0351398.ref011","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"R Meerwaldt","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"pone.0351398.ref012","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.jrn.2009.08.001","article-title":"Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging","volume":"20","author":"RD Semba","year":"2010","journal-title":"J Ren Nutr"},{"issue":"6","key":"pone.0351398.ref013","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MNH.0b013e32833e9259","article-title":"Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease","volume":"19","author":"AJ Smit","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"pone.0351398.ref014","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2215\/CJN.02420311","article-title":"Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3","volume":"6","author":"NJ McIntyre","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"pone.0351398.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083799","article-title":"Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study","volume":"8","author":"K Tanaka","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"pone.0351398.ref016","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"R Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"issue":"7","key":"pone.0351398.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003163","article-title":"The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study","volume":"17","author":"A Shardlow","year":"2020","journal-title":"PLoS Med"},{"issue":"16","key":"pone.0351398.ref018","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.3390\/jcm11164709","article-title":"A Prospective Analysis of Skin and Fingertip Advanced Glycation End-Product Devices in Healthy Volunteers","volume":"11","author":"D Adl Amini","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"pone.0351398.ref019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression Shrinkage and Selection Via the Lasso","volume":"58","author":"R Tibshirani","year":"1996","journal-title":"Journal of the Royal Statistical Society Series B: Statistical Methodology"},{"issue":"1","key":"pone.0351398.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"J Friedman","year":"2010","journal-title":"J Stat Softw"},{"issue":"2","key":"pone.0351398.ref021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel Inference","volume":"33","author":"KP Burnham","year":"2016","journal-title":"Sociological Methods & Research"},{"issue":"6","key":"pone.0351398.ref022","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10157-024-02497-4","article-title":"Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023","volume":"28","author":"Japanese Society of Nephrology","year":"2024","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"pone.0351398.ref023","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2004.02.008","article-title":"Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction","volume":"43","author":"JWL Hartog","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"pone.0351398.ref024","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/hc0702.104183","article-title":"Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses","volume":"105","author":"G Basta","year":"2002","journal-title":"Circulation"},{"issue":"16","key":"pone.0351398.ref025","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM200010193431609","article-title":"Inflammatory markers of coronary risk","volume":"343","author":"DJ Rader","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0351398.ref026","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1161\/ATVBAHA.116.307771","article-title":"Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease","volume":"36","author":"E Schutte","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"pone.0351398.ref027","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jdiacomp.2018.06.009","article-title":"Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes","volume":"32","author":"S Osawa","year":"2018","journal-title":"J Diabetes Complications"},{"issue":"7","key":"pone.0351398.ref028","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1464-5491.2010.03217.x","article-title":"Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue","volume":"28","author":"X Yue","year":"2011","journal-title":"Diabet Med"},{"issue":"5","key":"pone.0351398.ref029","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dme.12326","article-title":"Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population","volume":"31","author":"K Simon Klenovics","year":"2014","journal-title":"Diabet Med"},{"issue":"5","key":"pone.0351398.ref030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dia.2009.0113","article-title":"Reference values of skin autofluorescence","volume":"12","author":"M Koetsier","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"pone.0351398.ref031","doi-asserted-by":"crossref","first-page":"1700892","DOI":"10.3389\/fendo.2025.1700892","article-title":"Reference values and biological factors influencing skin autofluorescence","volume":"16","author":"BHR Wolffenbuttel","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"pone.0351398.ref032","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in Prevalence of Chronic Kidney Disease in the United States","volume":"165","author":"D Murphy","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"pone.0351398.ref033","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2018030296","article-title":"Sex-Related Disparities in CKD Progression","volume":"30","author":"AC Ricardo","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"pone.0351398.ref034","doi-asserted-by":"crossref","first-page":"514","DOI":"10.21037\/atm.2020.01.23","article-title":"The role of gender disparities in kidney injury","volume":"8","author":"RC Harris","year":"2020","journal-title":"Ann Transl Med"},{"issue":"4","key":"pone.0351398.ref035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment","volume":"28","author":"L Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"pone.0351398.ref036","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/01.ASN.0000068462.38661.89","article-title":"The effects of weight loss on renal function in patients with severe obesity","volume":"14","author":"A Chagnac","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:32:47Z","timestamp":1780939967000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351398"}},"subtitle":[],"editor":[{"given":"Donovan Anthony","family":"McGrowder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351398","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}